A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma.
Krüger J, Obenaus M, Blau IW, Hoser D, Vaegler M, Rauschenbach H, Anagnostopoulos I, Jöhrens K, Scheuplein V, Kieback E, Böhme J, Von Brünneck AC, Krönke J, Busse A, Willimsky G, Blankenstein T, Pezzutto A, Keller U, Nogai A.
Krüger J, et al. Among authors: hoser d.
Haematologica. 2024 Sep 12. doi: 10.3324/haematol.2024.286124. Online ahead of print.
Haematologica. 2024.
PMID: 39279443
Free article.